Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Pharmacokinetic interaction between tacrolimus and diltiazem - dose-response relationship in kidney and liver transplant recipientsJones, T.; Morris, R.
2013Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2005Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsDansirikul, C.; Duffull, S.; Morris, R.; Tett, S.
2007Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipientsWestley, I.; Taylor, P.; Salm, P.; Morris, R.
2002Cyclosporin monitoring in Australasia: Survey of laboratory practices in 2000Morris, R.; Lam, A.
2002International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoringHolt, D.; Armstrong, V.; Griesmacher, A.; Morris, R.; Napoli, K.; Shaw, L.
2005CEDIAƒ sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimensWestley, I.; Morris, R.; Taylor, P.; Salm, P.; James, M.
2000Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoringMorris, R.
2006Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: Effect of cyclosporineWestley, I.; Brogan, L.; Morris, R.; Evans, A.; Sallustio, B.
2005Immunosuppressant drug monitoring: Is the laboratory meeting clinical expectations?Morris, R.